Clinical Trial Update: Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy [Phase 3]

View source ↗

Summary

Compassionate-use update for metreleptin in people with generalized lipodystrophy in a Phase 3 program that remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Generalized Lipodystrophy
• Hyperlipidemia

Drugs mentioned

• Myalepta (metreleptin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Lipodystrophy, Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING